Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7024 studies found for:    vaccines
Show Display Options
Rank Status Study
1 Completed Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With Adjuvanted or Non-adjuvanted Influenza Vaccines
Condition: Prophylaxis of Avian Influenza Vaccine
Intervention: Biological: Fluad H5N1 Pandemic Influenza Vaccine
2 Completed Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009
Condition: Seasonal Influenza, Vaccine
Intervention: Biological: Seasonal Influenza Vaccine
3 Completed Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant
Condition: Plague Vaccine
Interventions: Biological: rF1V vaccine (with Adjuvant);   Biological: rF1V vaccine (without Adjuvant)
4 Unknown  Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV Infection
Condition: Vaccine Overdose of Undetermined Intent
Interventions: Biological: prophylactic peptide vaccine;   Biological: therapeutic peptide vaccine
5 Completed Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects
Condition: Prepandemic Influenza Vaccine
Intervention: Biological: Monovalent inactivated influenza vaccine
6 Recruiting Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation
Condition: Staphylococcal Vaccine
Interventions: Biological: Staphylococcus aureus 4-Antigen (SA4Ag) Vaccine;   Other: Placebo
7 Completed
Has Results
Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions
Conditions: Seasonal Influenza;   Vaccine
Interventions: Biological: Cell-derived influenza vaccine;   Biological: Egg-derived influenza vaccine
8 Completed Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
Condition: Botulism Vaccine
Interventions: Biological: Placebo (USP sterile saline for injection);   Biological: rBV A/B-40 vaccine
9 Completed Safety and Immunogenicity of One Dose of Inactivated Trivalent Flu Vaccine Administered to Non-elderly Adult and Elderly Subjects
Condition: Seasonal Influenza
Intervention: Biological: Trivalent subunit inactivated flu vaccine, Formulation 2010-2011
10 Completed Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly Subjects
Condition: Influenza Disease
Intervention: Biological: Influenza vaccine
11 Completed School Located Adolescent Vaccination Study
Condition: School Located Vaccine Program
Intervention: Behavioral: School Located Vaccine (SLV) Program
12 Completed
Has Results
Safety and Immunogenicity of Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture Using the Strain Composition 2007/2008
Condition: Seasonal Influenza Vaccine
Intervention: Biological: cTIV
13 Active, not recruiting Three Doses of Hepatitis A Vaccine in Patients With Immunomodulating Drugs
Condition: Vaccine Response Impaired
Intervention: Biological: hepatitis A vaccine
14 Completed Evaluation of the Safety and Immune Response to an Investigational Dengue Type 1 Vaccine
Condition: Dengue Virus
Interventions: Biological: Investigational Vaccine for DEN1;   Other: Placebo injection
15 Completed Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008
Condition: Influenza
Intervention: Biological: Surface antigen inactivated influenza vaccine
16 Completed A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2
Conditions: Japanese Encephalitis;   Japanese Encephalitis Vaccine
Intervention: Biological: Live attenuated Japanese encephalitis vaccine SA14-14-2
17 Active, not recruiting Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)
Conditions: Poliomyelitis;   Tropical Enteropathy
Intervention: Biological: IPV vaccination
18 Completed Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008
Conditions: Seasonal Influenza;   Vaccine
Intervention: Biological: trivalent split influenza vaccine
19 Completed Auto-immunity in Lupus Patients After Influenza Vaccine
Condition: Systemic Lupus Erythematosus (SLE)
Intervention: Drug: Vaccine
20 Completed Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules
Condition: Pre-pandemic Influenza Vaccine
Intervention: Biological: Monovalent inactivated influenza vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.